Skip to main content
. Author manuscript; available in PMC: 2017 Aug 18.
Published in final edited form as: Clin Res HIV AIDS. 2016 Nov 27;3(1):1031.

Figure 3. Cost effectiveness analysis for the combination HIV prevention interventions.

Figure 3

Discounted incremental costs and QALYS over 10 years are displayed for combined interventions

ART: Antiretroviral Therapy; HIV: Human Immunodeficiency Virus; HPV: Human Papillomavirus; Dual Vaccine: HIV and HPV Vaccinations; VMMC: Voluntary Male Medical Circumcision; Prep: Pre-Exposure Prophylaxis